Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News


December 31, 2013
Slow Progress in Getting Africans on ARVs Early in HIV Disease
The proportion of sub-Saharan Africans starting HIV drugs with advanced HIV disease is falling, but their median CD4 count at entry is increasing too slowly.
December 30, 2013
Young Adults Born With HIV Face Parenthood Challenges
As children born with HIV age into adulthood, they need guidance facing the additional challenges the virus poses if they consider becoming a parent.
December 27, 2013
New Anti-HIV Compounds Discovered
Researchers have identified a series of novel compounds that combat HIV and may one day lead to new options for antiretroviral treatment. 
December 26, 2013
Vaccine-Preventable HPV Common Among Young MSM
Young gay men acquire vaccine-preventable strains of HPV rapidly after becoming sexually active, adding weight to the CDC recommendation to vaccinated at 11 or 12.
December 24, 2013
Life Expectancy for Young People With HIV Is Nearly Normal
In the United States and Canada, the last decade saw life expectancies for young people living with HIV raise dramatically, to almost normal levels.
December 23, 2013
ARVs Cause Massive Gains in Life Expectancy in South Africa
Antiretrovirals (ARVs) added 9 to 11 years of life expectancy to HIV-positive South Africans who began treatment between 2004 and 2011.
December 20, 2013
HIV Causes AIDS by 'Cellular Suicide,' Not 'Viral Murder'
Defining for the first time exactly how HIV causes AIDS, scientists have found that the virus spurs the immune system into a suicidal overdrive.
December 19, 2013
Newly Discovered HIV Strain Progresses to AIDS in Only 5 Years
Scientists have discovered a strain of HIV in West Africa that progresses to AIDS in about five years, the shortest period of any known HIV-1 type.
December 18, 2013
ID Docs Widely Support PrEP, Yet Only 9% Write Scripts
Three in four ID doctors in the U.S. and Canada support pre-exposure prophylaxis (PrEP) to prevent HIV transmission, yet only 9 percent prescribe it.
December 17, 2013
FDA OKs Switching From Stable HIV Regimen to Complera
The FDA has approved Complera (emtricitabine/rilpivirine/tenofovir) for HIV-positive adults who switch from a stable ARV regimen.
December 16, 2013
Unsuppressed HIV Viral Load Doubles Heart Disease Risk
Having an unsuppressed HIV viral load appears to double the risk of structural heart disease.
December 13, 2013
Worldwide, Employment Is Linked to HIV Drug Adherence
People with HIV who have a job are more likely to adhere to their antiretrovirals, according to a new study out of the International Labour Organization.
December 12, 2013
Worse Seroconversion Illness Linked to Faster AIDS Diagnosis
The severity of seroconversion illness during primary HIV infection is linked to a shorter time before the development of AIDS-related conditions.
December 11, 2013
HIV Puts Gay Men With HPV at Greater Risk of Anal Cancer
Older HIV-positive men who have sex with men are at greater risk for strains of HPV that cause anal cancer when compared with HIV-negative MSM.
December 10, 2013
Testing New Inmates May Not Uncover Many New HIV Cases
Conducting HIV tests on inmates as they enter prison may not actually turn up more than a scant number of undiagnosed cases.
December 09, 2013
If CD4s Are High, A Multivitamin Combo Slows HIV Without ARVs
A particular combination of multivitamins along with selenium slows HIV disease among those who are treatment naive and have a CD4 count above 350.
December 06, 2013
Dashing Hopes, HIV Rebounds in 2 Men Once Potentially Cured
Two HIV-positive men who each displayed no signs of the virus after stem cell transplants to treat their lymphoma have both experienced a viral rebound.
FDA OKs Major New Hepatitis C Drug, Sovaldi (Sofosbuvir)
The FDA has approved Sovaldi (sofosbuvir), a once-daily oral nucleotide analog polymerase inhibitor to treat people with hepatitis C.
December 05, 2013
Katie Couric Is Slammed for Linking Harms to HPV Vaccine
Katie Couric has made scientifically unfounded claims on her talk show linking the HPV vaccine to dangerous side effects.
December 04, 2013
HIV Education, Risky Sex Not Linked to Testing in Urban Teens
Urban high schoolers who engage in risky sex and also have a high level of knowledge about HIV are not more inclined to undergo testing for the virus.
December 03, 2013
Unprotected Sex on the Rise Among Gay Men
Between 2005 and 2011, the rate of gay and bisexual men reporting unprotected anal intercourse in the past year increased 20 percent
December 02, 2013
Syringe Exchanges Prevent HIV: Just Ask Australia
Australia’s free and legal syringe exchange programs have led to an extremely low incidence of new HIV infections among injection drug users.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ



Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    fokisi
    Long Beach
    California


    soy_Ric
    Rochester
    New York


    cortaza100
    Oakland
    California


    blaze11212
    brooklyn
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.